GoodRx Holdings, Inc. provided earnings guidance for the third quarter of 2022. For the period, the company expected revenue to be approximately $185 million. This assumes the grocer issue has an estimated impact of $35 million to $40 million on third quarter prescription transactions revenue.

The company expects a greater impact quarter-over-quarter because the effect on the second quarter gradually increased as the quarter developed, whereas it started the third quarter facing a significant impact.